Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Ride On The CBD-Infused Beverage Trend

Published 09/12/2019, 10:55 PM
Updated 07/09/2023, 06:31 AM

Cannabidiol-infused (CBD) beverage market holds tremendous potential, owing to increasing health-consciousness among consumers, who are realizing the health benefits of CBD-infused drinks. Let us, thus, take a look at a couple of stocks that are positioned to gain from this new consumer trend.

CBD Beverages Market to Boom

According to a report by Zenith Global, the CBD-infused drinks market could be worth $1.4 billion by 2023, assuming a CAGR of 74.7%. There are ample reasons behind the popularity of CBD-infused drinks. First, consumer preference is shifting toward non-alcoholic beverages. Lower alcohol sales worldwide prove that. These could go further south as consumers step up on their demand for cannabidiol-infused beverages.

Second, CBD helps combat a string of health conditions such as arthritis, migraines, epilepsy, schizophrenia, insomnia, seizures, inflammation, the side effects of cancer and multiple sclerosis. The chemical has become more popular for relieving pain, offering relaxation and lifting one’s mood.

Third, product innovation is pushing sales. Sustainable and attractive packaging, ready-to-drink solutions, making ingredients public and a transparent consumer-producer relationship is building trust around products. When it comes to CBD beverages, these factors are rather crucial to making consumers return for more.

Finally, growing brand endorsements and knowledge of CBD-infused beverages are making these products hard to miss. In addition, speaking of a few CBD-infused products that are a hit among consumers, CBD-infused beer tops the list. Many notable brewers are now opting to manufacture the product.

Recently, California-based brewer Two Roots Brewing Co. said it is set to acquire Rochester Mills Production Brewery, the latter a Michigan-based craft beer producer. Two Roots plans to infuse, package and market cannabis-infused beer under its label.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

4 Stocks in Focus

We have chosen four beer and marijuana stocks that could gain big from the CBD-infused drinks rage. All of these stocks carry a Zacks Rank #2 (Buy) or 3 (Hold).

Anheuser-Busch InBev SA/NV (NYSE:BUD) announced a partnership with Tilray, Inc. (NASDAQ:TLRY) in December 2018 to produce marijuana-based beverages. The deal is worth $100 million.

Anheuser-Busch carries a Zacks Rank #2. In fact, the company’s stock has outperformed the Zacks Beverages – Alcohol industry on a year-to-date basis (+48.1% vs +28.1%). The Zacks Consensus Estimate for its current-year earnings has risen 8.8% over the past 60 days. You can see the complete list of today’s Zacks #1 Rank stocks here.

Per a CNBC report,The Boston Beer Company (NYSE:SAM) is seeking an entry into the cannabis market after its Truly Hard Seltzer turned the company’s stock price around.

Boston Beer Company carries a Zacks Rank #3. In fact, the company’s stock has outperformed the Zacks Beverages – Alcohol industry on a year-to-date basis (+63% vs +28.1%). The Zacks Consensus Estimate for its current-year earnings has risen 3.8% over the past 60 days.

Constellation Brands, Inc. (NYSE:STZ) is heavily invested in the cannabis market. The Corona beer producer first invested in Canopy Growth (CGC) in 2017 and has followed with more investments since then.

Constellation Brands carries a Zacks Rank #3. In fact, the company’s stock has outperformed the Zacks Beverages – Alcohol industry in the last six months (+19.6% vs +13.5%).

Aphria Inc. (TSX:APHA) is a major global cannabis company. The company holds a Tier 3 license to grow more than 5-acres cannabis for medical, scientific and therapeutic purposes.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Aphria carries a Zacks Rank #3. The Zacks Consensus Estimate for its current-year earnings has risen more than 100% over the past 60 days.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>



The Boston Beer Company, Inc. (SAM): Free Stock Analysis Report

Anheuser-Busch InBev SA/NV (BUD): Free Stock Analysis Report

Constellation Brands Inc (STZ): Free Stock Analysis Report

Tilray, Inc. (TLRY): Free Stock Analysis Report

Aphria Inc. (APHA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.